Post-doc, Institute for Behavioral Genetics, University of Colorado (USA)


Post-doctoral training opportunities are available through an NIH-funded T32 training grant administered through the National Institute on Drug Abuse (NIDA). IBG is one of the world’s leading institutes for genetic research on behavior. Internationally renowned research projects include the Colorado Adoption Project, the Colorado Twin Study and Longitudinal Twin Study, the Colorado Learning Disabilities Research Center, the Colorado Drug Research Center, and the Adolescent Brain and Cognitive Development (ABCD) Study. IBG is home to a DNA repository (about 40K samples) for research on human behavior, as well as studying behaviorally and genetically defined lines of selected, recombinant inbred, transgenic, and knockout-gene mice. Many faculty members work collaboratively across disciplines to study the underlying genetic and neurobiological factors contributing to risk for substance abuse.


Opportunities include training in data analysis of large-scale human genetic samples,
human developmental fMRI studies in adolescents, mouse behavioral studies of
substance use-related phenotypes, molecular genetics, mouse genetic mapping,
electrophysiology, transcriptome data analysis, among others. Please see
www.colorado.edu/ibg for more information about IBG and links to individual faculty
pages. Several investigators may serve as possible mentors for an outstanding
candidate who wishes to further their training in behavior genetics. Candidates are
encouraged to directly contact putative mentors to inquire about opportunities in
individual laboratories. Successful applicants will have the opportunity to supervise and
interact with junior graduate and undergraduate students. The position is restricted to
US citizens or Green Card holders because of the funding source. Applications from
underrepresented minorities are welcome. Formal submissions must be submitted CU
Jobs at https://jobs.colorado.edu/jobs/JobDetail/?jobId=28967.
The appointment would begin on June 30, 2021.